Digene to sell HPV (Human Papilloma Virus) test in Japan:
This article was originally published in Clinica
Executive Summary
Digene has received clearance in Japan to market its Hybrid Capture 2 HPV test for the detection of human papillomavirus, as a follow-up test to border line Pap smear results. The Gaithersburg, Maryland-based firm has also recently filed for US FDA approval to use the HPV DNA test in conjunction with the Pap smear as a primary screen for cervical cancer and its precursors in women age 30 and over.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.